CAIDE Score, Alzheimer’s Disease Pathology, and Cognition in Cognitively Normal Adults: The CABLE Study
Journal of Alzheimer’s Disease · 2024
DOI: 10.3233/jad-240005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Ze-Xin Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognition, Biomarkers, tau Proteins. Die Arbeit nennt 53 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
Cardiovascular Risk Factors, Ageing and Dementia (CAIDE) risk score serves as a credible predictor of an individual’s risk of dementia. However, studies on the link of the CAIDE score to Alzheimer’s disease (AD) pathology are scarce.
Objective
To explore the links of CAIDE score to cerebrospinal fluid (CSF) biomarkers of AD as well as to cognitive performance.
Methods
In the Chinese Alzheimer’s Biomarker and LifestylE (CABLE) study, we recruited 600 cognitively normal participants. Correlations between the CAIDE score and CSF biomarkers of AD as well as cognitive performance were probed through multiple linear regression models. Whether the correlation between CAIDE score and cognitive performance was mediated by AD pathology was researched by means of mediation analyses.
Results
Linear regression analyses illustrated that CAIDE score was positively associated with tau-related biomarkers, including pTau ( p < 0.001), tTau ( p < 0.001), as well as tTau/Aβ42 ( p = 0.008), while it was in negative association with cognitive scores, consisting of MMSE score ( p < 0.001) as well as MoCA score ( p < 0.001). The correlation from CAIDE score to cognitive scores was in part mediated by tau pathology, with a mediation rate varying from 3.2% to 13.2%.
Conclusions
A higher CAIDE score, as demonstrated in our study, was linked to more severe tau pathology and poorer cognitive performance, and tau pathology mediated the link of CAIDE score to cognitive performance. Increased dementia risk will lead to cognitive decline through aggravating neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
- Shandong Xiehe University, Jinan, Shandong, China.
- Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Zitieren
APA
Guo, Z. X., Liu, F., Wang, F. Y., Ou, Y. N., Huang, L. Y., Hu, H., Wang, Z. B., Fu, Y., Gao, P. Y., Tan, L., & Yu, J. T. (2024). CAIDE Score, Alzheimer’s Disease Pathology, and Cognition in Cognitively Normal Adults: The CABLE Study. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-240005
Vancouver
Guo ZX, Liu F, Wang FY, Ou YN, Huang LY, Hu H, et al. CAIDE Score, Alzheimer’s Disease Pathology, and Cognition in Cognitively Normal Adults: The CABLE Study. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-240005
BibTeX
@article{Guo2024,
author = {Guo, Ze-Xin and Liu, Fang and Wang, Fang-Yuan and Ou, Ya-Nan and Huang, Liang-Yu and Hu, Hao and Wang, Zhi-Bo and Fu, Yan and Gao, Pei-Yang and Tan, Lan and Yu, Jin-Tai},
title = {CAIDE Score, Alzheimer’s Disease Pathology, and Cognition in Cognitively Normal Adults: The CABLE Study},
journal = {Journal of Alzheimer’s Disease},
year = {2024},
doi = {10.3233/jad-240005}
}
EUVIMED